Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1147 ARTÍCULOS , VIENDO DEL 1006 AL 1020

Predicting cognitive decline in Alzheimer's disease: an integrated analysis

Lopez OL, Schwam E, Cummings J, Gauthier S, Jones R, Wilkinson D, Waldemar G, Zhang R, Schindler R.

Alzheimers Dement. 2010 Nov;6(6):431-9. doi: 10.1016/j.jalz.2010.04.003.

Genetics of Alzheimer disease

Bekris LM, Yu CE, Bird TD, Tsuang DW.

J Geriatr Psychiatry Neurol. 2010 Dec;23(4):213-27. doi: 10.1177/0891988710383571.

Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here?

Saxena U.

Expert Opin Ther Targets. 2010 Dec;14(12):1273-7. doi: 10.1517/14728222.2010.528285.

How useful is the IQCODE for discriminating between Alzheimer's disease, mild cognitive impairment and subjective memory complaints?

Sikkes SA, van den Berg MT, Knol DL, de Lange-de Klerk ES, Scheltens P, Uitdehaag BM, Klein M, Pijnenburg YA.

Dement Geriatr Cogn Disord. 2010;30(5):411-6. doi: 10.1159/000321697. Epub 2010 Nov 11.

Late onset Alzheimer's disease in older people

Isik AT.

Clin Interv Aging. 2010 Oct 11;5:307-11. doi: 10.2147/CIA.S11718.

Development and validation of the Memory Orientation Screening Test (MOST™): A better screening test for dementia

Clionsky MI, Clionsky E.

Am J Alzheimers Dis Other Demen. 2010 Dec;25(8):650-6. doi: 10.1177/1533317510386216.

Factors of error and effort in memory intervention for patients with Alzheimer's disease and amnesic syndrome

Mimura M, Komatsu S.

Psychogeriatrics. 2010 Dec;10(4):179-86. doi: 10.1111/j.1479-8301.2010.00339.x.

[Effects of amyloid β-protein on hippocampal long-term potentiation]

Zhang JF, Yang D, Qi JS.

Sheng Li Xue Bao. 2010 Dec 25;62(6):479-88.

Interleukin-6 gene (-174 C/G ) and apolipoprotein E gene polymorphisms and the risk of Alzheimer disease in a Polish population

Klimkowicz-Mrowiec A, Wołkow P, Spisak K, Maruszak A, Styczyńska M, Barcikowska M, Szczudlik A, Słowik A.

Neurol Neurochir Pol. 2010 Nov-Dec;44(6):537-41. doi: 10.1016/s0028-3843(14)60149-3.

Preventing Alzheimer's disease and cognitive decline

Williams JW, Plassman BL, Burke J, Benjamin S.

Evid Rep Technol Assess (Full Rep). 2010 Apr;(193):1-727.

Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain

Simpson JE, Ince PG, Lace G, Forster G, Shaw PJ, Matthews F, Savva G, Brayne C, Wharton SB; MRC Cognitive Function and Ageing Neuropathology Study Group.

Neurobiol Aging. 2010 Apr;31(4):578-90. doi: 10.1016/j.neurobiolaging.2008.05.015. Epub 2008 Jun 30.

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study

Lewczuk P, Kamrowski-Kruck H, Peters O, Heuser I, Jessen F, Popp J, Bürger K, Hampel H, Frölich L, Wolf S, Prinz B, Jahn H, Luckhaus Ch, Perneczky R, Hüll M, Schröder J, Kessler H, Pantel J, Gertz HJ, Klafki HW, Kölsch H, Reulbach U, Esselmann H, Maler JM, Bibl M, Kornhuber J, Wiltfang J.

Mol Psychiatry. 2010 Feb;15(2):138-45. doi: 10.1038/mp.2008.84. Epub 2008 Jul 29.

Epigenetic changes in Alzheimer's disease: decrements in DNA methylation

Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD, Rogers J.

Neurobiol Aging. 2010 Dec;31(12):2025-37. doi: 10.1016/j.neurobiolaging.2008.12.005. Epub 2008 Dec 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias